Morocco vs Tajikistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Morocco
77.0%
in 2025
Tajikistan
79.0%
in 2025
Morocco rank
122nd
Tajikistan rank
119th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Morocco
- Tajikistan
How they compare
Tajikistan currently reports 79.0% against 77.0% in Morocco, a difference of 2.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tajikistan ahead.
Morocco ranks 122nd and Tajikistan ranks 119th of 192 countries.
Morocco has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Morocco | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 75.5% | 0.0% | 75.5% | Morocco |
| 2020s | 89.3% | 31.3% | 58.0% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Morocco or Tajikistan?
- Tajikistan, at 79.0% against 77.0% in Morocco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Morocco and Tajikistan?
- 2.0%, with Tajikistan ahead.
- How many years of comparable data are there for Morocco and Tajikistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Morocco and Tajikistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Morocco ranks 122nd and Tajikistan ranks 119th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.